Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX) Insider Trading
Directors, officers and holders of more than 10% of PCRX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 106 transactions on file: 0 with code P, 12 with code S and 38 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | RIKER LAUREN | Senior Vice President, Finance | S Sale | 6,000 | $36.32 | $217,920 |
| Oct 8, 2026 | RIKER LAUREN | Senior Vice President, Finance | M Exercise | 6,000 | $32.35 | $194,100 |
| Oct 8, 2026 | RIKER LAUREN | Senior Vice President, Finance | M Exercise | 6,000 | Not measured | Not measured |
| Aug 17, 2026 | SLONIN JONATHAN | Chief Medical Officer | S Sale | 3,040 | $23.23 | $70,619 |
| Jun 11, 2026 | RIKER LAUREN | Senior Vice President, Finance | S Sale | 6,115 | $23.50 | $143,703 |
| Jun 10, 2026 | CHRISTIE CHRISTOPHER | Director | A Award | 6,405 | Not measured | Not measured |
| Jun 10, 2026 | BIGAL MARCELO | Director | A Award | 10,891 | Not measured | Not measured |
| Jun 10, 2026 | YANG MICHAEL J. | Director | A Award | 10,891 | Not measured | Not measured |
| Jun 10, 2026 | CHRISTIE CHRISTOPHER | Director | A Award | 10,891 | Not measured | Not measured |
| Jun 10, 2026 | Froimson Mark | Director | A Award | 6,405 | Not measured | Not measured |
| Jun 10, 2026 | Hirawat Samit | Director | A Award | 10,891 | Not measured | Not measured |
| Jun 10, 2026 | Hirawat Samit | Director | A Award | 6,405 | Not measured | Not measured |
| Jun 10, 2026 | Young Alethia | Director | A Award | 6,405 | Not measured | Not measured |
| Jun 10, 2026 | WIGGANS THOMAS G | Director | A Award | 32,675 | Not measured | Not measured |
| Jun 10, 2026 | Brege Laura | Director | A Award | 6,405 | Not measured | Not measured |
| Jun 10, 2026 | YANG MICHAEL J. | Director | A Award | 6,405 | Not measured | Not measured |
| Jun 10, 2026 | BIGAL MARCELO | Director | A Award | 6,405 | Not measured | Not measured |
| Jun 10, 2026 | Young Alethia | Director | A Award | 10,891 | Not measured | Not measured |
| Jun 10, 2026 | Froimson Mark | Director | A Award | 10,891 | Not measured | Not measured |
| Jun 10, 2026 | Brege Laura | Director | A Award | 10,891 | Not measured | Not measured |
| Jun 4, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | S Sale | 10,259 | $22.27 | $228,468 |
| Jun 3, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | F Tax Payment | 8,528 | $22.32 | $190,345 |
| Jun 3, 2026 | RIKER LAUREN | Senior Vice President, Finance | F Tax Payment | 3,187 | $22.32 | $71,134 |
| Jun 3, 2026 | SLONIN JONATHAN | Chief Medical Officer | F Tax Payment | 4,728 | $22.32 | $105,529 |
| Apr 23, 2026 | Cross Shawn | Chief Financial Officer | M Exercise | 12,941 | Not measured | Not measured |
| Apr 23, 2026 | Cross Shawn | Chief Financial Officer | S Sale | 12,941 | $25.16 | $325,596 |
| Apr 23, 2026 | Cross Shawn | Chief Financial Officer | M Exercise | 12,941 | $16.45 | $212,879 |
| Apr 22, 2026 | Cross Shawn | Chief Financial Officer | S Sale | 1,500 | $25.01 | $37,515 |
| Apr 22, 2026 | Cross Shawn | Chief Financial Officer | M Exercise | 1,500 | Not measured | Not measured |
| Apr 22, 2026 | Cross Shawn | Chief Financial Officer | M Exercise | 1,500 | $16.45 | $24,675 |
| Apr 21, 2026 | Cross Shawn | Chief Financial Officer | M Exercise | 2,845 | Not measured | Not measured |
| Apr 21, 2026 | Cross Shawn | Chief Financial Officer | S Sale | 2,845 | $25.01 | $71,153 |
| Apr 21, 2026 | Cross Shawn | Chief Financial Officer | M Exercise | 2,845 | $16.45 | $46,800 |
| Apr 20, 2026 | Cross Shawn | Chief Financial Officer | M Exercise | 7,714 | Not measured | Not measured |
| Apr 20, 2026 | Cross Shawn | Chief Financial Officer | S Sale | 7,714 | $25.14 | $193,930 |
| Apr 20, 2026 | Cross Shawn | Chief Financial Officer | M Exercise | 7,714 | $16.45 | $126,895 |
| Mar 17, 2026 | Froimson Mark | Director | S Sale | 500 | $21.81 | $10,905 |
| Mar 17, 2026 | SLONIN JONATHAN | Chief Medical Officer | S Sale | 3,261 | $22.82 | $74,416 |
| Feb 11, 2026 | Lee Frank D. | Chief Executive Officer | A Award | 261,818 | Not measured | Not measured |
| Feb 11, 2026 | SLONIN JONATHAN | Chief Medical Officer | A Award | 54,546 | Not measured | Not measured |
| Feb 11, 2026 | RIKER LAUREN | Senior Vice President, Finance | A Award | 19,273 | Not measured | Not measured |
| Feb 11, 2026 | Teehan Brendan | Chief Commercial Officer | A Award | 51,714 | Not measured | Not measured |
| Feb 11, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | A Award | 54,546 | Not measured | Not measured |
| Feb 11, 2026 | Cross Shawn | Chief Financial Officer | A Award | 49,091 | Not measured | Not measured |
| Feb 2, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | S Sale | 13,137 | $20.53 | $269,703 |
| Feb 2, 2026 | RIKER LAUREN | Senior Vice President, Finance | S Sale | 4,000 | $20.81 | $83,240 |
| Jan 30, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | F Tax Payment | 17,134 | $20.54 | $351,932 |
| Jan 30, 2026 | RIKER LAUREN | Senior Vice President, Finance | F Tax Payment | 2,751 | $20.54 | $56,506 |
| Jan 30, 2026 | Lee Frank D. | Chief Executive Officer | F Tax Payment | 41,488 | $20.54 | $852,164 |
| Jan 30, 2026 | Teehan Brendan | Chief Commercial Officer | F Tax Payment | 5,182 | $20.54 | $106,438 |
The full Form 4 history is on the PCRX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.